Biofabri's TB vaccine collaboration presses ahead with vacci...

A collaboration between Biofabri, a non-profit organisation, and academics from South Africa are pressing ahead with clinical development of a novel tuberculosis vaccine candidate known as

GSK’s TB vaccine makes a big step forward towards licensing

MSF calls for J&J to cut price of TB medicine

The humanitarian medical organisation Medecins Sans Frontieres (MSF) has called on Johnson & Johnson to cut the price of its anti-tuberculosis medicine Sirturo (bedaquiline), to not mor

Not-for-profit gets tuberculosis drug approved ahead of big ...

The FDA has approved a new drug to treat certain types of multi-drug resistant tuberculosis – but it’s taken a not-for-profit organisation supported by governments and the billionaire phila

GSK TB vaccine shows promise, but more trials needed

GlaxoSmithKline’s experimental TB vaccine has shown that it could help prevent the disease, but further research is needed to identify patients with the strongest response.